Page 101

101

Part C or D

Measure

Measure Type

Weight

Measurement Year

Improvement Measure Included in the 2026 CAI Values C Reviewing Appeals Decisions Measures Capturing Access 2 1/1/2024 – 12/31/2024 Yes No C Call Center – Foreign Language Interpreter and TTY Availability Measures Capturing Access 2 2/2025 – 5/2025 Yes No D Call Center – Foreign Language Interpreter and TTY Availability Measures Capturing Access 2 2/2025 – 5/2025 Yes No D Complaints about the Drug Plan Patients’ Experience and Complaints Measure 2 1/1/2024 – 12/31/2024 Yes No D Members Choosing to Leave the Plan Patients’ Experience and Complaints Measure 2 1/1/2024 – 12/31/2024 Yes No D Drug Plan Quality Improvement Improvement Measure 5 NA No No D Rating of Drug Plan Patients’ Experience and Complaints Measure 2 3/2025 – 6/2025 Yes No D Getting Needed Prescription Drugs Patients’ Experience and Complaints Measure 2 3/2025 – 6/2025 Yes No D MPF Price Accuracy Process Measure 1 1/1/2024 – 9/30/2024 Yes No D Medication Adherence for Diabetes Medications Intermediate Outcome Measure 3 1/1/2024 – 12/31/2024 Yes Yes D Medication Adherence for Hypertension (RAS antagonists) Intermediate Outcome Measure 3 1/1/2024 – 12/31/2024 Yes Yes D Medication Adherence for Cholesterol (Statins) Intermediate Outcome Measure 3 1/1/2024 – 12/31/2024 Yes Yes D MTM Program Completion Rate for CMR Process Measure 1 1/1/2024 – 12/31/2024 Yes Yes D Statin Use in Persons with Diabetes Process Measure 1 1/1/2024 – 12/31/2024 Yes Yes *Measure has a weight of 1 for the 2026 Star Ratings because it is considered a new measure.